Piper Sandler: 'We are buyers of Guardant Health (GH)'
April 16, 2026 7:55 AM
Piper Sandler analyst David Westenberg reiterated an Overweight rating and $130.00 price target on Guardant Health (NASDAQ: GH).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
